The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 10, 2009

Filed:

Oct. 11, 2005
Applicants:

Chisato Makino, Kawasaki, JP;

Nobutaka Ninomiya, Kawasaki, JP;

Haruo Orita, Kawasaki, JP;

Hidetoshi Sakai, Kawasaki, JP;

Akira Yabuki, Kawasaki, JP;

Nobuo Kato, Tokyo, JP;

Shigeru Shioya, Tokyo, JP;

Inventors:

Chisato Makino, Kawasaki, JP;

Nobutaka Ninomiya, Kawasaki, JP;

Haruo Orita, Kawasaki, JP;

Hidetoshi Sakai, Kawasaki, JP;

Akira Yabuki, Kawasaki, JP;

Nobuo Kato, Tokyo, JP;

Shigeru Shioya, Tokyo, JP;

Assignee:

Ajinomoto Co., Inc., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61K 9/22 (2006.01); A61K 9/24 (2006.01); A61K 9/36 (2006.01);
U.S. Cl.
CPC ...
Abstract

There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a drug capable of decreasing the post prandial blood glucose level of diabetic patients close to the normal level, or mixing a controlled release drug capable of decreasing the post prandial blood glucose level close to the normal level with an immediate release drug. It is particularly preferable that the drug capable of decreasing the post prandial blood glucose level close to the normal level is nateglinide.


Find Patent Forward Citations

Loading…